OPTHEA
Who is OPTHEA?
Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic macular edema (DME), which remain leading causes of vision loss worldwide. Opthea’s lead product candida...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2012 (14 years)
Address:
SUITE 0403, LEVEL 4, 650 CHAPEL STREET; TOORAK; SOUTH YARRA, VIC 3141, AU
Employees by Department
- Operations (1)
- The Rest (5)
- Total (6)
Key Decision Makers
Karen Adams Fgia Fcg
Vice President Finance and Company Secretary
Amy Brady
Finance Manager
Johanna Mendoza
Director of Operations
Ian Leitch
Senior Director of Clinical Research
Employees by Seniority
C-level
1employees
Senior
1employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has OPTHEA been operating for?
- What is the funding status of OPTHEA?
- Where is OPTHEA's headquarter?
- What OPTHEA's spending power?
- Does OPTHEA have a presence in the domain it operates in?